FAM162A is a mitochondrial protein implicated in apoptosis, mitochondrial dynamics, and bioenergetics. Key findings from recent studies include:
FAM162A localizes to the inner mitochondrial membrane (IMM), particularly within cristae, where it interacts with OPA1 to regulate mitochondrial fusion . Loss of FAM162A disrupts cristae structure, leading to:
FAM162A mediates hypoxia-induced apoptosis by:
Facilitating AIFM1 translocation to the nucleus in neuronal cells .
Modulating mitochondrial permeability transition pore (mPTP) opening via VDAC interaction .
Paradoxically, FAM162A overexpression in cancers (e.g., cervical, gastric) correlates with enhanced proliferation under hypoxia . In Drosophila models, human FAM162A overexpression extends lifespan by 25% under normal conditions and 40% under heat stress .
Cellular Studies: COS7 cells transfected with FAM162A variants (e.g., FAM-N-GFP, FAM-C-GFP) for protease protection assays to confirm IMM localization .
Organismal Models: Transgenic Drosophila overexpressing human FAM162A to assess longevity and stress resistance .
FAM162A shows high conservation across taxa, with recombinant proteins available for multiple species:
| Species | Expression System | Tag | Key Features |
|---|---|---|---|
| Pongo abelii | E. coli | His | Full-length (1–154 aa), mitochondrial targeting |
| Homo sapiens | E. coli/Mammalian | His/GST | Partial/full-length variants for functional studies |
| Mus musculus | E. coli | His | Full-length (1–155 aa) for rodent model studies |
Topological Ambiguity: Conflicting predictions about transmembrane domains (2 vs. 1) require further structural validation.
Dual Roles in Apoptosis vs. Survival: Mechanisms underlying FAM162A’s pro-apoptotic vs. pro-survival functions in cancer require elucidation .
Therapeutic Potential: Exploring FAM162A as a target for mitochondrial diseases or cancer therapies .
FAM162A is proposed to regulate apoptosis, although the precise mechanism may vary across cell types and tissues. It may be involved in hypoxia-induced cell death in transformed cells, potentially through cytochrome C release, caspase activation (e.g., CASP9), and induction of mitochondrial permeability transition. In neuronal cells, it may contribute to hypoxia-induced cell death by facilitating the release of AIFM1 from mitochondria to the cytoplasm and its subsequent nuclear translocation. However, the involvement of caspases in this process remains inconsistently reported.
KEGG: pon:100173874
STRING: 9601.ENSPPYP00000015084
FAM162A (Family with sequence similarity 162 member A, also known as E2IG5, HGTD-P, and C3orf28) is a mitochondrial protein highly conserved across evolutionary taxa. Localization studies using protease protection assays in COS7 cells have definitively shown that FAM162A resides predominantly in the inner mitochondrial membrane (IMM), particularly within the cristae . This localization is significant as it contradicts earlier bioinformatic predictions suggesting outer mitochondrial membrane placement.
For researchers investigating FAM162A localization, fluorescence protease protection assays using constructs with GFP tags at either N-terminus (FAM-N-GFP) or C-terminus (FAM-C-GFP) provide reliable results. Control experiments should include co-transfection with markers for both intermembrane space (Omp25_mCherry) and mitochondrial matrix (pmMitoTurquoise) .
Several experimental approaches have proven effective for FAM162A research:
When working with recombinant FAM162A protein, appropriate storage conditions (−20°C, avoid repeated freeze-thaw cycles) are critical for maintaining protein integrity. For extended storage, conservation at −20°C or −80°C is recommended .
FAM162A plays a crucial role in maintaining mitochondrial ultrastructure and promoting fusion dynamics. Loss-of-function experiments in COS7 cells demonstrate that FAM162A knockdown results in:
Significant shift in mitochondrial morphology: Increase in punctate mitochondria (from 21% to 34%) and decrease in networked mitochondria (from 26% to 9%)
Altered mitochondrial ultrastructure: FAM162A-silenced cells show smaller mitochondria with increased circularity and contain abnormal "bubble-like" swollen mitochondria with outer membrane disruption
OPA1 regulation: FAM162A knockdown causes approximately 50% reduction in OPA1 levels without affecting other fusion (MFN1, MFN2) or fission (DRP1, phosphorylated DRP1, FIS1) proteins
To investigate these structural changes, researchers should employ both confocal microscopy with mitochondrial stains (e.g., TMRE) and transmission electron microscopy. Quantitative analysis should classify mitochondrial units into morphological categories (puncta, large/round, rod, network) and measure parameters including area, perimeter, and circularity .
This apparent contradiction presents a fascinating research challenge. FAM162A was initially identified as a pro-apoptotic protein involved in hypoxia-induced cell death, yet it is paradoxically overexpressed in several cancer types where it appears to promote proliferation rather than apoptosis .
To investigate this dual functionality, researchers should consider:
Bioenergetic profiling: Measure oxygen consumption rates (OCR) using Seahorse technology to determine how FAM162A affects basal respiration, maximal respiration, and spare respiratory capacity in normal versus cancer cells
Cell viability assays: Compare the effects of FAM162A manipulation (knockdown/overexpression) on cell viability (MTT assay) and mortality (LDH assay) in normal and cancer cell lines
Stress response experiments: Expose cells to various stressors (hypoxia, oxidative stress, nutrient deprivation) and measure how FAM162A affects survival outcomes
Mitochondrial turnover assessment: Use fluorescent reporters like MitoTimer to track mitochondrial turnover rates in different contexts
Recent experiments show that FAM162A knockdown reduces cell viability by approximately 30% and increases mortality by 30% in normal cells, suggesting it plays a pro-survival role under normal conditions that may be exploited in cancer .
FAM162A significantly impacts mitochondrial bioenergetics. When examining FAM162A-silenced cells:
Mitochondrial membrane potential decreases by approximately 50% as measured by TMRE staining
Respiratory parameters show significant impairment:
For comprehensive bioenergetic assessment, researchers should:
Use Seahorse XF Analyzer to measure oxygen consumption rate (OCR) under various conditions (basal, following oligomycin, FCCP, and rotenone/antimycin A addition)
Combine with TMRE staining in non-quenching mode to assess membrane potential
Analyze OXPHOS protein expression via immunoblotting
Consider mitophagy and mitochondrial turnover rates using MitoTimer or similar fluorescent reporters
Interestingly, the respiratory deficits observed in FAM162A-deficient cells occur despite normal expression levels of OXPHOS proteins, suggesting functional rather than expression-level regulation .
Transgenic Drosophila overexpressing human FAM162A (hFAM162A_OE) have revealed significant physiological effects:
Extended lifespan: 25% increase in survival compared to control flies (both Control-Gal4 and Control UAS_FAM162A) at 29°C
Sex-specific effects: Female flies showed approximately 12.5% greater extension in lifespan than males
Enhanced stress resistance: Under heat stress conditions (40°C), hFAM162A_OE flies demonstrated significantly improved survival
To generate similar models, researchers should:
Clone human FAM162A cDNA (optimized for Drosophila codon usage) into the pUASTattB-5xUAS/Mini_Hsp70 vector
Use the UAS/GAL4 system for targeted expression (e.g., Tubulin-GAL4 for ubiquitous expression)
For lifespan studies, house 20 flies per condition at 29°C with daily monitoring
For stress tests, subject flies to 40°C and record survival and locomotor activity
Normalize velocity parameters by fly weight
This in vivo model provides compelling evidence that FAM162A functions as a pro-survival factor at the organismal level.
Determining the precise topology of FAM162A has been challenging, with conflicting predictions in the literature. To resolve this question:
Protease protection assays: Generate constructs with fluorescent tags (e.g., GFP) at either N-terminus or C-terminus and assess protease sensitivity
Structural modeling: Use AlphaFold 2.0 or similar AI-based modeling software to predict protein structure. Current models suggest FAM162A contains two transmembrane segments, an extended loop with a short alpha-helix domain, and a C-terminus alpha-helix structure
Site-directed mutagenesis: Create targeted mutations in potential membrane-spanning regions to assess their importance for localization and function
Super-resolution microscopy: Employ techniques like STORM or PALM with specific markers for different mitochondrial compartments to precisely localize FAM162A
Immuno-EM: Use gold-labeled antibodies against FAM162A for electron microscopy visualization of the exact cristae localization
These approaches collectively provide a comprehensive view of FAM162A's topology, which appears to differ from earlier bioinformatic predictions suggesting a single transmembrane segment in the outer mitochondrial membrane .
FAM162A significantly impacts mitochondrial quality control mechanisms and stress responses:
Mitochondrial turnover: Experiments with the fluorescent MitoTimer reporter showed that FAM162A overexpression enhances mitochondrial turnover rates under both basal and stressed conditions. After paraquat (oxidative stress) treatment, FAM162A-overexpressing cells maintained a significantly higher proportion of newly synthesized mitochondria compared to controls
Oxidative stress resistance: FAM162A appears to protect against oxidative stress-induced damage, as evidenced by both cellular experiments and transgenic Drosophila models
To investigate these aspects, researchers should:
Use reporters like MitoTimer that change fluorescence properties with age (green→red shift indicates aging mitochondria)
Apply stress inducers like paraquat (100μM) to assess mitochondrial response
Quantify the ratio of new (green) to old (red) mitochondria under various conditions
Correlate mitochondrial turnover with other parameters such as membrane potential and respiratory capacity
These methodologies can help elucidate FAM162A's role in maintaining mitochondrial health under stress conditions.
The significant reduction in OPA1 levels following FAM162A knockdown suggests an important functional relationship between these proteins . To explore this interaction:
Co-immunoprecipitation: Use antibodies against FAM162A to pull down protein complexes and probe for OPA1, or vice versa
Proximity ligation assay (PLA): Detect potential direct interaction between the two proteins in situ
Super-resolution microscopy: Visualize co-localization at nanometer-scale resolution
Rescue experiments: Test whether OPA1 overexpression can rescue phenotypes caused by FAM162A knockdown
Domain mapping: Create truncated or mutated versions of both proteins to identify interaction domains
This relationship is particularly significant as OPA1 is a key regulator of cristae morphology and mitochondrial fusion. Understanding how FAM162A regulates OPA1 could provide insights into the mechanisms underlying FAM162A's effects on mitochondrial structure and dynamics .